Jump to the top of the page

William Blair News

Keep up to date on our recent transactions, announcements, and events.

A hand holding a smartphone in front of a laptop

News and Events

  • Equity Research

    William Blair Initiates Coverage of Three Oil and Gas Companies

    William Blair initiated research coverage of APA Corporation, Coterra Energy Inc., and Ovintiv Inc.

    Read more
  • Investment Banking

    CIH Has Agreed to be Acquired by Tokio Marine

    William Blair acted as exclusive financial advisor to Commodity & Ingredient Hedging, LLC, a portfolio company of Falfurrias Capital Partners, in connection with its pending sale to Tokio Marine Holdings, Inc.

    Read more
  • Investment Banking

    CallRevu Has Been Acquired by Astira Capital Partners

    William Blair acted as the exclusive financial advisor to CallRevu, a portfolio company of Serent Capital, in connection with its sale to Astira Capital Partners.

    Read more
  • Investment Banking

    William Blair Acts as Joint Active Bookrunner on BillionToOne’s Initial Public Offering

    William Blair acted as a joint active bookrunner on the $314.0 million initial public offering for BillionToOne, Inc. (Nasdaq: BLLN), a high-growth, commercial-stage precision diagnostics company transforming healthcare through its proprietary single-molecule next-generation sequencing (smNGS) platform.

    Read more
  • Investment Banking

    PSG Equity Has Made a Minority Investment in SavvyMoney

    William Blair served as exclusive financial advisor to PSG Equity (PSG) in connection with its minority investment in SavvyMoney, a portfolio company of Spectrum Equity.

    Read more
  • Equity Research

    William Blair Initiates Coverage of Five Companies in the Rare Earth Industry

    William Blair initiated research coverage of USA Rare Earth, Inc. (USAR $28.54), United States Antimony Corporation (UAMY $12.56), American Resources Corporation (AREC $4.25), NioCorp Developments Ltd. (NB $8.30), and Royalty Management Holding Corporation (RMCO $2.96).

    Read more
  • Equity Research

    Climb Bio, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Climb Bio, Inc. (CLYM $1.88), which is developing high-impact medicines for patients living with autoimmune diseases, with the CD19 antibody budoprutug as its lead program.

    Read more
News search

Awards and Recognition

  • Private Wealth Management

    The Cultra Wealth Management Group Recognized as a Top Team by Forbes

    Congratulations to the Cultra Wealth Management Group for being named on Forbes magazine’s America’s Top Wealth Management Teams list, released November 12.

    Read more
  • Equity Research

    Top Wall Street Analysts

    TipRanks acknowledged seven William Blair equity research analysts among the top 10%, reflecting their ability to outperform their peers with expertise and stock selection.

    Read more
  • Corporate

    William Blair Honored as One of the Top Workplaces in Chicago for 2025

    William Blair was named one of Chicago’s Top Workplaces for 2025 by the Chicago Tribune on November 5.

    Read more
  • Private Wealth Management

    Eight William Blair Colleagues Named Top Next-Gen Wealth Advisor Best-in-State by Forbes

    Congratulations to the firm’s largest group to make Forbes’ annual listing, released on August 6.

    Read more
  • Equity Research

    Top Wall Street Analysts

    TipRanks acknowledged seven William Blair equity research analysts among the top 10%, reflecting their ability to outperform their peers with expertise and stock selection.

    Read more
  • Corporate

    William Blair Among the Most Charitable Companies in Massachusetts

    William Blair is honored to be named in the Boston Business Journal's annual Corporate Citizenship Awards, recognizing the region’s top corporate charitable contributors.

    Read more
Search awards and recognition

In The Media

  • Investment Banking

    Matt Zimmer Discusses Deal Outlook, PE Strategy, Secondaries on Bloomberg TV

    Global Head of Investment Banking Matt Zimmer recently appeared on Bloomberg TV’s “Open Interest” program.

    Read more
  • Investment Management

    Marcelo Assalin Quoted in IPE’s Emerging Markets Debt Issue

    William Blair Investment Management portfolio manager Marcelo Assalin was included in financial services sector magazine IPE’s focus coverage on emerging markets debt as an asset class in the current investing landscape.

    Read more
  • Investment Banking

    Stewart Licudi Discusses European Investment Banking Trends, Firm Growth in S&P Global

    William Blair’s head of European investment banking Stewart Licudi was featured in S&P Global Market Intelligence, where he outlined investment banking and private equity investing trends in 2025 as well as William Blair’s recent growth and planned expansion in the market.

    Read more
  • Investment Banking

    Axios Cites Biopharma Investment Banking’s “Quarterly Rx” Report

    Axios turned to William Blair’s Biopharma investment banking group and its “Quarterly Rx” report for insights in a recent story on IPO and investing activity in the sector.

    Read more
  • Equity Research

    Jed Dorsheimer Joins CNBC’s “Squawk Box” to Discuss Tesla Q3 Unit Delivery Numbers

    William Blair equity research analyst Jed Dorsheimer was a featured guest on CNBC’s “Squawk Box” to discuss the implications of the auto manufacturer’s Q3 2025 unit delivery numbers.

    Watch the video
Search media mentions

Contact Us

Please contact Padraic Swanton with any media-related inquiries or to request a complete media kit.

+1 312 364 5290
pswanton@williamblair.com

For inquiries related to Equity Research, please contact Chris Thonis.

+1 312 364 8565
cthonis@williamblair.com

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Subscribe to News Alerts

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures